Review | Published:

Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials

International Journal of Obesity volume 41, pages 16071614 (2017) | Download Citation

Abstract

Gut microbiota is important for maintaining body weight. Modulation of gut microbiota by probiotics may result in weight loss and thus help in obesity treatment. The aim of this systematic review was to evaluate the effects of Lactobacillus on weight loss and/or fat mass in overweight adults. A search was performed on the Medline (PubMed) and Scopus electronic databases using the search terms: ‘probiotics’, ‘Lactobacillus, ‘obesity’, ‘body weight changes’, ‘weight loss’, ‘overweight’, ‘abdominal obesity’, ‘body composition’, ‘body weight’, ‘body fat’ and ‘fat mass’. In the total were found 1567 articles, but only 14 were included in this systematic review. Of these nine showed decreased body weight and/or body fat, three did not find effect and two showed weight gain. Results suggest that the beneficial effects are strain dependent. It can highlight that Lactobacillus plantarum and Lactobacillus rhamnosus when combined with a hypocaloric diet, L. plantarum with Lactobacillus curvatus, Lactobacillus gasseri, Lactobacillus amylovorus, Lactobacillus acidophilus and Lactobacillus casei with phenolic compounds, and multiple species of Lactobacillus.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    World Health Organization (WHO). Fact sheet: Obesity and Overweight, n. 311, 2015. Available at: (accessed 20 July 2016).

  2. 2.

    Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica (ABESO)Diretrizes Brasileiras de Obesidade: 2009/20103.. AC Farmacêutica: São Paulo, 2009.

  3. 3.

    , , , . The relationship between gut microbiota and weight gain in humans. Future Microbiol 2012; 7: 91–109.

  4. 4.

    , , , , . Lipopolysaccharides impair insulin gene expression in isolated islets of langerhans via toll-like receptor-4 and NF-kB signalling. PLoS One 2012; 7: e36200.

  5. 5.

    , . Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm 2013; 2013: 986734.

  6. 6.

    , , , . The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome. Front Endocrinol 2014; 5: 47.

  7. 7.

    , , , , . The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis 2016; 15: 108.

  8. 8.

    Brasil. ANVISA. Agência Nacional de Vigilância Sanitária. Resolução RDC nº 2, de 7 de janeiro de 2002. Aprova o regulamento técnico de substâncias bioativas e probióticos isolados com alegação de propriedades funcional e/ou de saúde. Diário Oficial da União, Poder Executivo, 9 Jan 2002. Available at: (accessed: 20 July 2016).

  9. 9.

    , , . Intestinal microbiota: relevance to obesity and modulation by prebiotics and probiotics. Nutr Hosp 2013; 28: 1039–1348.

  10. 10.

    , , . Probiotics and their effects on metabolic diseases: an update. J Clin Diagn Res 2013; 7: 173–177.

  11. 11.

    , , , , , . The effect of yoghurt and its probiotics on blood pressure and serum lipid profile: a randomized controlled trial. Nutr Metab Cardiovasc Dis 2015; 25: 46–51.

  12. 12.

    , Cochrane Handbook for Systematic Reviews of Interventions version 5.1. 0. Updated March 2011. The Cochrane Collaboration 2011. Available at: (accessed: 20 July 2016).

  13. 13.

    , , , , , et al. Probiotic improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg 2009; 13: 1198–1204.

  14. 14.

    , , , , , et al. The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. Eur J Clin Nutr 2012; 66: 1110–1115.

  15. 15.

    , , , , . Evaluation of a phyto-supplement efficacy as adjuvant in reducing body weight and fat mass in overweight women. Curr Top Nutraceutical Res 2013; 11: 21–28.

  16. 16.

    , , , , , et al. Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial. Korean J Farm Med 2013; 34: 80–89.

  17. 17.

    , , , , , et al. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomized controlled trail. Br J Nutr 2013; 110: 1696–1703.

  18. 18.

    , , , , . Lactobacillus fermentum and Lactobacillus amylovorus as probiotics alter body weight adiposity and gut microflora in healthy persons. J Funct Food 2013; 5: 116–123.

  19. 19.

    , , , , , et al. Hypocaloric diet supplementation with probiotic cheese improves body index and blood pressure indices hypertensive patients - a randomized double-blind placebo-controlled pilot study. Nutr J 2013; 12: 138–149.

  20. 20.

    , , , , , et al. Short communication: effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function in subjects with metabolic syndrome—a pilot study. J Dairy Sci 2013; 96: 89–95.

  21. 21.

    , , , , , et al. Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduced body adiposity and Lp-PLA2 activity in overweight subjects. J Funct Foods 2015; 19: 744–752.

  22. 22.

    , , , , , et al. Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity. FEBS Open Biol 2016; 6: 64–76.

  23. 23.

    , , , , , . Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000; 54: 288–297.

  24. 24.

    , , , , , et al. Regulation of abdominal adipocity by probiotics (Lactobaacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 2010; 64: 636–643.

  25. 25.

    , , , , , et al. Effect of Lactobacillus rhamnosus CGMCC13724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 2014; 111: 1507–1519.

  26. 26.

    , , , , , et al. Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism in overweight and mildly obese individuals: a randomized controlled trial. Microb Ecol Health Dis 2016; 27: 30312.

  27. 27.

    , , , , , et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 2010; 5: e13087.

  28. 28.

    , , , , , et al. Insulin sensitivity, insulin secretion, and abdominal fat: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 2003; 52: 2490–2496.

  29. 29.

    , , , , , et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39–48.

  30. 30.

    , , . Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. J Microbiol 2010; 48: 712–714.

  31. 31.

    , , , , , et al. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 2008; 99: 1013–1017.

  32. 32.

    , , , , . Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet. J Nutr Sci 2016; 5: e23.

  33. 33.

    , , , . Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 2014; 53: 599–606.

  34. 34.

    , , , , . Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 2009; 4: e7125.

  35. 35.

    , , , , , et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes 2012; 36: 817–825.

  36. 36.

    , , , , , et al. Correlation between body mass index and gut concentrations of Lactobacillus reuteriBifidobacterium animalisMethanobrevibacter smithii and Escherichia coli. Int J Obes 2013; 37: 1460–1466.

  37. 37.

    , . Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microb Ecol Health Dis 2000; 12: 247–285.

  38. 38.

    , , , , , et al. Effect of functional yogurt NY-YP901 in improving the trait of metabolic syndrome. Eur J Clin Nutr 2011; 65: 1250–1255.

  39. 39.

    , , , , , . Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection. Nutr Diabetes 2014; 4: e109.

  40. 40.

    , , , , , et al. Visceral adiposity and the risk of impaired glucose tolerance a prospective study among Japanese Americans. Diabetes Care 2003; 26: 650–655.

  41. 41.

    , , . Lactobacillus plantarum LG42 isolated from gajami sik-hae decreases body and fat pad weights indiet-induced obese mice. J Appl Microbiol 2014; 116: 145–156.

  42. 42.

    , , , , , et al. Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age. Br J Nutr 2011; 106: 887–895.

  43. 43.

    , , , . Aspectos tecnológicos de alimentos funcionais contendo probióticos. Rev Bras Cienc Farm 2002; 38: 1–21.

Download references

Author information

Affiliations

  1. Institute of Nutrition Josué de Castro, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    • L Crovesy
    • , M Ostrowski
    • , E L Rosado
    •  & M Soares-Mota
  2. Library of Health Sciences Center, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

    • D M T P Ferreira

Authors

  1. Search for L Crovesy in:

  2. Search for M Ostrowski in:

  3. Search for D M T P Ferreira in:

  4. Search for E L Rosado in:

  5. Search for M Soares-Mota in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to L Crovesy.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/ijo.2017.161

Further reading